Rosenbaum C - Search Results

1

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO Jr, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC. Dewys WD, et al. Among authors: rosenbaum c. Am J Med. 1980 Oct;69(4):491-7. doi: 10.1016/s0149-2918(05)80001-3. Am J Med. 1980. PMID: 7424938

2

Treatment of grade III and IV astrocytoma with dimethyl triazeno imidazole carboxamide (DTIC, NSC-45388) alone and in combination with CCNU (NSC-79037) or methyl CCNU (MeCCNU, NSC-95441).

Taylor SG, Nelson L, Baxter D, Rosenbaum C, Sponzo RW, Cunningham TJ, Olson KB, Horton J. Taylor SG, et al. Among authors: rosenbaum c. Cancer. 1975 Oct;36(4):1269-76. doi: 10.1002/1097-0142(197510)36:4<1269::aid-cncr2820360412>3.0.co;2-#. Cancer. 1975. PMID: 169984

3

Tamoxifen in advanced prostate cancer: an ECOG pilot study.

Horton J, Rosenbaum C, Cummings FJ. Horton J, et al. Among authors: rosenbaum c. Prostate. 1988;12(2):173-7. doi: 10.1002/pros.2990120207. Prostate. 1988. PMID: 3368405

4

A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma.

Schoenfeld DA, Rosenbaum C, Horton J, Wolter JM, Falkson G, DeConti RC. Schoenfeld DA, et al. Among authors: rosenbaum c. Cancer. 1982 Dec 15;50(12):2757-62. doi: 10.1002/1097-0142(19821215)50:12<2757::aid-cncr2820501211>3.0.co;2-j. Cancer. 1982. PMID: 7139566

5

Selection of treatment for lymphoma.

Horton J, Baxter D, Cunningham TJ, Rosenbaum C, Taylor SG. Horton J, et al. Among authors: rosenbaum c. N Engl J Med. 1973 Aug 16;289(7):378-9. doi: 10.1056/nejm197308162890721. N Engl J Med. 1973. PMID: 4718525 No abstract available.

6

Comparison of 5-azacytidine (NSC-102816) with CCNU (NSC-79037) in the treatment of patients with breast cancer and evaluation of the subsequent use of cyclophosphamide (NSC-26271).

Cunningham TJ, Nemoto T, Rosner D, Knight E, Taylor S, Rosenbaum C, Horton J, Dao T. Cunningham TJ, et al. Among authors: rosenbaum c. Cancer Chemother Rep. 1974 Sep-Oct;58(5 Pt 1):677-81. Cancer Chemother Rep. 1974. PMID: 4138966 No abstract available.

7

Adriamycin: comparison of a 5-week schedule with a 3-week schedule in the treatment of breast cancer.

Knight EW, Horton J, Cunningham T, Rhie F, Lagakos S, Rosenbaum C, Taylor S 4th, Tennant J. Knight EW, et al. Among authors: rosenbaum c. Cancer Treat Rep. 1979 Jan;63(1):121-2. Cancer Treat Rep. 1979. PMID: 369683 Clinical Trial. No abstract available.

8

Phase II evaluation of dibromodulcitol, ICRF-159, and maytansine for sarcomas.

Borden EC, Ash A, Enterline HT, Rosenbaum C, Laucius JF, Paul AR, Falkson G, Lerner H. Borden EC, et al. Among authors: rosenbaum c. Am J Clin Oncol. 1982 Aug;5(4):417-20. doi: 10.1097/00000421-198208000-00012. Am J Clin Oncol. 1982. PMID: 6956236

9

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.

Borden EC, Amato DA, Rosenbaum C, Enterline HT, Shiraki MJ, Creech RH, Lerner HJ, Carbone PP. Borden EC, et al. Among authors: rosenbaum c. J Clin Oncol. 1987 Jun;5(6):840-50. doi: 10.1200/JCO.1987.5.6.840. J Clin Oncol. 1987. PMID: 3585441 Clinical Trial.

10

Phase II trial of ifosfamide with mesna in previously treated metastatic sarcoma.

Antman KH, Montella D, Rosenbaum C, Schwen M. Antman KH, et al. Among authors: rosenbaum c. Cancer Treat Rep. 1985 May;69(5):499-504. Cancer Treat Rep. 1985. PMID: 3924401

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters